Skip to main content
Clinical Trials/NCT03143829
NCT03143829
Completed
Not Applicable

Promoting Cancer Symptom Management in Older Adults

University of Central Florida1 site in 1 country80 target enrollmentAugust 11, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neoplasms
Sponsor
University of Central Florida
Enrollment
80
Locations
1
Primary Endpoint
Symptom Severity Change Over Time
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The purpose of the project is to estimate the effect size of a technology based intervention for older adults with cancer for nausea and vomiting. Participants will be randomized to either an intervention or a wait control group. Outcomes such as symptom severity, quality of life and resource use will be examined.

Detailed Description

The goal of this study is to increase the self-management behaviors for chemotherapy induced nausea and vomiting (CINV) and reduce treatment-related negative outcomes in older adults with cancer. CINV is a common reason for unplanned emergency department and/or hospital admissions in older adults with cancer. Early reinforcement of standard education and reframing preconceived beliefs about the potential serious consequences of CINV and the symptoms ability to be successfully managed will increase effective self-management behaviors and improve patient outcomes

Registry
clinicaltrials.gov
Start Date
August 11, 2016
End Date
August 31, 2018
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Men and women age 65 and older
  • newly diagnosed with any cancer
  • treatment with any chemotherapeutic agent with a moderate to severe emetic potential (on a 3- or 4- week cycle)
  • proficient in English
  • have a telephone.

Exclusion Criteria

  • Patients with previous diagnosis and treatment for cancer
  • advanced or end stage disease with a palliative intent
  • visually or hearing impaired.

Outcomes

Primary Outcomes

Symptom Severity Change Over Time

Time Frame: assessed at baseline (week 1), week 4,week 7, week 10. differences between groups at week 10 are being reported

Symptom Representation Questionnaire (SRQ)\[20\] , a 24-item self-report measure will be used to identify presence and severity of common treatment-related symptoms (0-10 Likert scale), including nausea and vomiting (N/V). This measure asks respondents to think about their symptoms over the past week. Higher values indicate a worse outcome

Self-management Behaviors Over Time

Time Frame: data was assessed at weeks 4,7, 10, the mean number of behaviors (behaviors) combined at each time point is reported

An investigator-developed Symptom Management Checklist (SMC) will measure CINV self-management prevention behaviors. Participants will complete this daily at home between chemotherapy cycles. Higher numbers indicate more frequent management.

Health-related Quality of Life Change Over Time

Time Frame: assessed at baseline (week 1), week 4, week 7, week 10. the difference between groups at week 10 is being reported

The EORTC-30\[21\] will measure QOL at each treatment cycle. 0-10 scale, higher scores mean better outcome

Resource Use Over Time

Time Frame: assessed at weeks 4,7,10. the total number of admissions was summed across all time points and participants

Any unplanned Emergency Department or hospital admission will be recorded via participant report. Higher number indicate higher resource use.

Study Sites (1)

Loading locations...

Similar Trials